Insulet Corporation (PODD) is a Healthcare · Medical Devices company listed on NASDAQ. Price $140.60 (-0.67%), Market cap $10.21B, P/E ratio 34.53, 52-week low–high $147.46 ~ $352.82.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provide
Financial statements, price targets, institutional (13F) holdings and related news for Insulet Corporation are updated in real time on BlackAll Trade.
Insulet Corporation trades at $140.60 (-0.67%). Real-time quotes and charts are available on BlackAll Trade.
Insulet Corporation has a market cap of about $10.21B. Its P/E ratio is 34.53.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform